Overall, these studies examining factors that might modulate DMH NPY demonstrated a novel anorectic action of central TTR in the control of energy balance (38), providing a potential novel target for obesity treatment. The gene discussed is TTR; the disease is obesity due to melanocortin 4 receptor deficiency.